Maria Sauro

I have several decades of experience in executive pharmaceutical sales, sales training and market access. I am confident that my skill set would transferrable into the GOP sphere. My determination to succeed certainly will prevail!

MARIA SAURO Greater Orlando Area Phone: 689.777.9076 Email: asheville4233@charter.net LinkedIn: www.linkedin.com/in/maria-s-abb88213 Career Overview Exemplary work ethic with time tested results throughout my sales career with industry leaders in the biotechnology arena has provided me the opportunity to utilize both entrepreneurial & specialized medical talents (laboratory, operating room, cath lab) within the oncologic, rare disease & critical care space. Emphasis on patient advocacy, building solid client relationships, project metrics oversight, daily sales results accountability and closing sales. Consistently finished each year over 100% since inception into hospital medical sales arena. Finished in the Top 10% and won 12 awards for sales, business ingenuity and “best in class” clinical presentation skills (per direct report testimonials) within pharmaceutical industry. Represented both large and small molecules with heavy emphasis on Biologics/Biotech agents. Professional Experience Ashfield Healthcare 2022 to Present Pharmaceutical Education Rep Short-term contractual outsourcing alliance for first iteration critical care Pfizer product. Clientele includes primary care IM and FP physicians as well as pharmacies. Queen Medical Supplies/ABC Medical Principal Owner/VP of Sales Assistant 2020-2022 Pioneering the development of a start-up business venture with the principal owner for southeastern USA. Coordinating business contracts in procurement/supply chain departments for medical supplies within IDNS/hospitals, surgical suites, physician offices and other ancillary sites. Astra Zeneca Pharmaceuticals Infectious Dis./Resp. TA 2015 - 2019 Health Systems Manager Market Access Cross-Functional Position covering 3 state geography: FL, GA, AL. Role included collaborating within AZ model while representing MABs - Synagis & Fasenra in 20 academic institutions (340 B). Building key opinion leader advocacy (KOLs) & territory equity while strongly advocating for underserved populations: premature Infants, VA (Orphan-Esoph.Granulomatosis), indigent programs. Delivered sophisticated clinical/business presentations to C/D-suite level clinician stakeholders & regional advocates to authenticate reimbursement landscape. Clientele included: allergists/immunologists, pulmonologists, neonatologists, oncologists (infusion centers), pediatric cardiologists, pharmacists, pediatric intensivists, NPs, QA/risk management, P&T members, CPI, Population Health, IT Infrastructure, VA/DOD. Collaboration team included: BSSs, DSMs, FRMs, FMDs. • Ranked #1 (of 8) Lead ID Atlanta team sales driven initiatives to 110% 1st year 2015-16 • Drove Florida team sales up over 200% - UF Shands, Mt. Sinai, Johns Hopkins 2015-2016 • Won “Directors Achievement Award” Dec. 2016 awarded by VP of Sales/Strategic Alliance due to #1 Ranking for Transition of Care referral placement for premature infants (Synagis) • #1 HSM (of 16) to gain all 10 Academic Formulary Wins (Part B) for Fasenra Launch 2018 • #1 HSM (of 16) to achieve TOC establishment in all 20 IDN targets by end of 2018 - ensured every pre-term infant had Access to Synagis post-discharge per Access 360/Medicaid • Achieved “4” Exceeds Exp. Rating (18 out of 301 in ID franchise) 1st Perf. Review 2016 • Achieved “4” Exceed Exp. Rating (12 out of 305 in ID Franchise) 2nd Perf. Review 2017 • Organized/led Medicaid Directives via Dept Dirs/Chiefs for Level 2 NICU infants FL/GA • Promulgated RSV Cardiology C.P. Guidelines/Best Practice Algorithms - 4 IDNs/Ped.Hosp. • HSM Team Leader as Compliance Ambassador/Ethics Trainer 2018 & 2019 • Strong Buy & Bill experience interfacing with ASOCs, Specialty Pharmacies, Oncology Infusion Clinics. Garnered EHR/EMR protocol/hub service algorithms through scientific exchange Marathon Pharmaceuticals 2014-2015 Regional Account Director Rare Disease Accelerated business composition strategies for Deflazacort (Duchenne’s), Iprivask (Ortho hospitals) & pain product Zingo (lidocaine hydrochloride monohydrate) in 5 state geography (FL, GA, MS, AL, SC) to pediatric hospitals; gaining formulary approval within IDN hospital systems. Clientele included: pharmacists, hematology/oncologists, vascular/orthopaedic surgeons, ER, CPI, Value-Analysis. Trained 70 reps. • Landed 2 new corporate accounts within first 6 months: GuideWell/Crucial Care ER Clinics • 2 Formulary Wins 1st Quarter - Greenville Memorial Children’s Hospital & Shriners Tampa • Gained 1st Zingo evaluation after just 2 weeks in the Florida Territory, Imaging/Cardiac Care Thermo Fisher Scientific 2010–2014 Clinical Diag. Device Manager Precipitated market share increases for Molecular Diagnostic Oncology/